These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23802813)

  • 1. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
    Carmody LA; Zhao J; Schloss PD; Petrosino JF; Murray S; Young VB; Li JZ; LiPuma JJ
    Ann Am Thorac Soc; 2013 Jun; 10(3):179-87. PubMed ID: 23802813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability.
    Hampton TH; Thomas D; van der Gast C; O'Toole GA; Stanton BA
    Microbiol Spectr; 2021 Sep; 9(1):e0002921. PubMed ID: 34232099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
    Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
    Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.
    Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
    ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
    Carmody LA; Caverly LJ; Foster BK; Rogers MAM; Kalikin LM; Simon RH; VanDevanter DR; LiPuma JJ
    PLoS One; 2018; 13(3):e0194060. PubMed ID: 29522532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis.
    Sherrard LJ; Einarsson GG; Johnston E; O'Neill K; McIlreavey L; McGrath SJ; Gilpin DF; Downey DG; Reid A; McElvaney NG; Boucher RC; Muhlebach MS; Elborn JS; Tunney MM
    J Cyst Fibros; 2019 Nov; 18(6):808-816. PubMed ID: 30905581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics.
    Smith DJ; Badrick AC; Zakrzewski M; Krause L; Bell SC; Anderson GJ; Reid DW
    Eur Respir J; 2014 Oct; 44(4):922-30. PubMed ID: 25034564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decade-long bacterial community dynamics in cystic fibrosis airways.
    Zhao J; Schloss PD; Kalikin LM; Carmody LA; Foster BK; Petrosino JF; Cavalcoli JD; VanDevanter DR; Murray S; Li JZ; Young VB; LiPuma JJ
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5809-14. PubMed ID: 22451929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway microbiota across age and disease spectrum in cystic fibrosis.
    Zemanick ET; Wagner BD; Robertson CE; Ahrens RC; Chmiel JF; Clancy JP; Gibson RL; Harris WT; Kurland G; Laguna TA; McColley SA; McCoy K; Retsch-Bogart G; Sobush KT; Zeitlin PL; Stevens MJ; Accurso FJ; Sagel SD; Harris JK
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29146601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.
    Zemanick ET; Wagner BD; Harris JK; Wagener JS; Accurso FJ; Sagel SD
    Pediatr Pulmonol; 2010 Jun; 45(6):569-77. PubMed ID: 20503282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation.
    Carmody LA; Zhao J; Kalikin LM; LeBar W; Simon RH; Venkataraman A; Schmidt TM; Abdo Z; Schloss PD; LiPuma JJ
    Microbiome; 2015; 3():12. PubMed ID: 25834733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
    Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
    Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway bacterial community composition in persons with advanced cystic fibrosis lung disease.
    Thornton CS; Carmody LA; Kalikin LM; Opron K; Caverly LJ; LiPuma JJ
    J Cyst Fibros; 2023 Jul; 22(4):623-629. PubMed ID: 36628831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung function and microbiota diversity in cystic fibrosis.
    Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
    Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung microbiota across age and disease stage in cystic fibrosis.
    Coburn B; Wang PW; Diaz Caballero J; Clark ST; Brahma V; Donaldson S; Zhang Y; Surendra A; Gong Y; Elizabeth Tullis D; Yau YC; Waters VJ; Hwang DM; Guttman DS
    Sci Rep; 2015 May; 5():10241. PubMed ID: 25974282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.